Patent Shorting Strategy

A hedge fund employs a unique strategy by shorting pharmaceutical stocks and challenging their patents in court. If successful in invalidating a patent, the stock price plummets, leading to significant profits for the fund. This approach is likened to a reverse patent troll, showcasing a clever twist on traditional investment tactics.